The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

IPSC FINANCIAL STATEMENTS

Century Therapeutics Inc — balance sheet, income statement and cash flow trends

IPSCCentury Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M0100 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-29.1 M $ · -Infinity%Operating Income-118.8 M $ · -Infinity%Pre-tax Income-109.9 M $ · -Infinity%Net Income to Owners-109.8 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-29.1 M $-133.3%
Operating Income-118.8 M $—
EBITDA-97.1 M $—
Net Income to Owners-109.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets287 M
  • Equity232.3 M $81%
  • Current Liabilities15.1 M $5%
  • Long-term Liabilities39.6 M $14%

Key Figures

YoY change
Total Assets287 M $+0.8%
Total Liabilities54.7 M $-26.9%
Total Equity232.3 M $+10.7%
Cash & ST Investments119.7 M $-23.2%
Total Debt34.6 M $-32.7%
Net Debt-15 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M050 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M0-86.8 M $Operating-47.8 M $Investing127 M $Financing-7.6 M $Net Change

Key Figures

YoY change
Operating Cash Flow-86.8 M $—
Capital Expenditures1.7 M $-4.0%
Free Cash Flow-87.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on IPSC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.